Alnylam 's R&D program created several treatments for rare diseases, benefitting over 3,495 patients
Register to read the full analysis —or— Upgrade to access more features
#research
#Development
#genetic diseases
#medicine
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.